Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study
Recruiting
N/A
Interventional Study
Ischemic Stroke, Acute
Rehabilitation Outcome
Cerebrolysin
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- University Medical Centre Ljubljana · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Being able to perform ARAT test Signed informed consent
Both sexes, age not specified
Acute ischemic stroke confirmed by imaging
NIHSS score 6-12
No prior stroke or disability (mRS 0 before stroke)
\-
Exclusion Criteria:
Not being able to perform ARAT test
* Previous str…
Contacts